HSBC Holdings plc set a €61.00 ($71.76) target price on Compugroup Medical SE (ETR:COP) in a report published on Wednesday. The firm currently has a buy rating on the stock.

Several other research firms have also recently issued reports on COP. Baader Bank set a €52.00 ($61.18) price target on shares of Compugroup Medical SE and gave the stock a neutral rating in a research note on Wednesday, September 20th. Berenberg Bank set a €53.00 ($62.35) price target on shares of Compugroup Medical SE and gave the stock a neutral rating in a research note on Tuesday, September 19th. Deutsche Bank AG set a €60.00 ($70.59) price target on shares of Compugroup Medical SE and gave the stock a buy rating in a research note on Thursday, August 24th. Finally, Warburg Research set a €52.00 ($61.18) price target on shares of Compugroup Medical SE and gave the stock a neutral rating in a research note on Thursday, August 3rd. Three analysts have rated the stock with a hold rating and two have assigned a buy rating to the stock. The stock currently has a consensus rating of Hold and an average price target of €55.60 ($65.41).

Compugroup Medical SE (ETR:COP) traded down 2.54% during trading on Wednesday, reaching €48.65. 362 shares of the company’s stock traded hands. The firm has a 50 day moving average of €48.66 and a 200 day moving average of €48.24. The firm has a market capitalization of €2.42 billion and a PE ratio of 53.17. Compugroup Medical SE has a 1-year low of €36.21 and a 1-year high of €52.80.

COPYRIGHT VIOLATION WARNING: “Compugroup Medical SE (COP) Given a €61.00 Price Target at HSBC Holdings plc” was first published by The Cerbat Gem and is owned by of The Cerbat Gem. If you are accessing this article on another publication, it was copied illegally and republished in violation of international trademark and copyright law. The original version of this article can be read at https://www.thecerbatgem.com/2017/10/19/compugroup-medical-se-cop-given-a-61-00-price-target-at-hsbc-holdings-plc.html.

Compugroup Medical SE Company Profile

CompuGroup Medical Societas Europaea develops and sells software, as well as information technology services for healthcare sector worldwide. It operates through three segments: Health Provider Services I, Health Provider Services II, and Health Connectivity Services. The company is involved in the development and sale of practice management software and electronic medical records for office-based physicians, dentists, medical care centers, and physician’s networks; and integral clinical, administrative, and financial software applications for pharmacies and mail order pharmacies.

Analyst Recommendations for Compugroup Medical SE (ETR:COP)

Receive News & Stock Ratings for Compugroup Medical SE Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Compugroup Medical SE and related stocks with our FREE daily email newsletter.